Original articlesBreast tumorsPembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 study
Breast tumors
Under an Elsevier user license
open archive
Key words
anti-PD-1
immunotherapy
pembrolizumab
triple-negative breast neoplasms
Cited by (0)
Footnotes
Note: This study was previously presented at American Society of Clinical Oncology 2017 Annual Meeting, June 2–6, 2017, Chicago, IL, USA; abstract 1008.
Copyright © 2019 THE AUTHORS. Published by Elsevier Ltd. All rights reserved.